HAP40, or Huntingtin-associated protein 40, is a vital component involved in intracellular transportation and vesicle trafficking within neurons. Primarily situated in the endoplasmic reticulum and Golgi apparatus, HAP40 interacts with various proteins essential for protein folding, sorting, and trafficking, contributing to neuronal function. Its association with huntingtin, a protein linked to Huntington's disease, suggests a role in neurodegeneration, alongside its involvement in synaptic vesicle trafficking and neurotransmitter release.
Inhibition of HAP40 presents a potential avenue for modulating intracellular trafficking pathways, potentially attenuating the pathological effects linked to neurodegenerative diseases. Mechanisms of inhibition may encompass targeting specific protein-protein interactions involving HAP40, disrupting its binding to other trafficking proteins, or altering its subcellular distribution. Additionally, small molecules or peptides could be designed to interfere with HAP40 function, either by directly binding to the protein or by influencing downstream signaling pathways that regulate its activity. Understanding the precise molecular mechanisms of HAP40 inhibition is crucial for unraveling potential strategies to modulate intracellular trafficking and counteract neurodegenerative processes associated with conditions like Huntington's disease.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, which may be upstream of HAP40, affecting its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, potentially altering HAP40 function if part of the PI3K pathway. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $102.00 $138.00 | 14 | |
Inhibits AKT, which could modulate HAP40 activity indirectly if HAP40 is involved in AKT signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
MEK inhibitor, could affect HAP40 if it's part of the MAPK/ERK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor, potentially alters HAP40 activity if HAP40 functions in this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which might modify HAP40 activity if HAP40 is associated with the JNK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, could affect HAP40 activity if HAP40 is involved in mTOR signaling. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Src kinase inhibitor, could alter HAP40 function if HAP40 interacts with Src family kinases. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Inhibits Bcr-Abl tyrosine kinase, which might influence HAP40 if it interacts with this kinase. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
CDK4/6 inhibitor, could affect HAP40 activity if HAP40 has a role in cell cycle regulation. | ||||||